Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease

Acta Neuropathologica

Volumn 117, Issue 1, 2009, Pages 19-29

  Woodhouse, Adele ^a   Shepherd, Claire E ^b,c   Sokolova, Anna ^a   Carroll, Victoria L ^a   King, Anna E ^a   Halliday, Glenda M ^b,c   Dickson, Tracey C ^a   Vickers, James C ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cotton wool plaques; Dystrophic neurites; Familial Alzheimer's disease; Neurofibrillary tangles; Presenilin 1

Indexed keywords

AMYLOID BETA PROTEIN; DIRECT YELLOW 7; PRESENILIN 1; THIOFLAVINE; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; NEURITE; NEUROFIBRILLARY TANGLE; NONHUMAN; ONSET AGE; PATHOGENESIS; PHENOTYPE; PLAQUE FORMING CELL; PRIORITY JOURNAL; RABBIT;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; AUTOPSY; BLOTTING, WESTERN; COHORT STUDIES; CYTOSKELETON; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; PRESENILIN-1; SENILE PLAQUES; SEVERITY OF ILLNESS INDEX; TAU PROTEINS; THIAZOLES;

EID: 57049098091     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-008-0458-z     Document Type: Article

References (54)

1. Akiyama H, Schwab C, Kondo H et al (2002) Morphologically distinct plaque types differentially affect dendritic structure and organization in the early and late stages of Alzheimer's disease. Acta Neuropathol 103:377-383
2. Armstrong RA (1998) β-Amyloid plaques: Stages in life history or independent origin? Dement Geriatr Cogn Disord 9:227-238
3. Biernat J, Wu Y-Z, Timm T et al (2002) Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. Mol Biol Cell 13:4013-4028
4. Blanchard V, Moussaoui S, Czech C et al (2003) Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice. Exp Neurol 184:247-263
5. Borchelt DR, Thinakaran G, Eckman CB et al (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17:1005-1013
6. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
7. Busciglio J, Lorenzo A, Yeh J, Yanker BA (1995) β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14:879-888
8. Campion D, Dumanchin C, Hannequin D et al (1999) Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65:664-670
9. Chen Q, Nakajima A, Choi SH, Xiong X, Tang YP (2008) Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse. J Neurosci Res 86:1615-1626
10. Crook R, Verkkoniemi A, Perez-Tur J et al (1998) A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to the deletion of exon 9 of presenilin 1. Nat Med 4:452-455
11. Czech C, Tremp G, Pradier L (2000) Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms. Prog Neurobiol 60:363-384
12. De Felice FG, Wu D, Lambert MP et al (2008) Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Abeta oligomers. Neurobiol Aging 29:1334-1347
13. Dickson TC, Chuckowree JA, Chuah MI, West AK, Vickers JC (2005) Novel Alzheimer's disease pathology reflects variable neuronal vulnerability and demonstrates the role of β-amyloid plaques in neurodegeneration. Neurobiol Dis 18:286-295
14. Dickson TC, Vickers JC (2001) The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience 105:99-107
15. Dickson TC, King CE, McCormack GH, Vickers JC (1999) Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. Exp Neurol 156:100-110
16. Dowjat WK, Wisniewski H, Wisniewski T (2001) Alzheimer's disease presenilin-1 expression modulates the assembly of neurofilaments. Neuroscience 103:1-8
17. Evans J, Sumners C, Moore J et al (2002) Characterisation of mitotic neurons derived from adult rat hypothalamus and brain stem. J Neurophysiol 87:1076-1085
18. Ferreira A, Lu Q, Orecchio L, Kosik KS (1997) Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar Abeta. Mol Cell Neurosci 9:220-234
19. Fukumoto H, Asami-Odaka AS, Uzuki N, Iwatsubo T (1996) Association of Aβ40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals. Neurodegeneration 5:13-17
20. Giannakopoulos P, Herrmann FR, Bussiere T et al (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60:1495-1500
21. Gomez-Isla T, Growdon WB, McNamara MJ et al (1999) The impact of different presenilin 1 and presenilin 2 mutation on amyloid deposition neurofibrillary changes and neuronal loss in familial Alzheimer's disease brain: Evidence for other phenotype-modifying factors. Brain 122:1709-1719
22. Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M (1998) Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau. Nat Neurosci 1:355-358
23. Houlden H, Baker M, McGowan E et al (2000) Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol 48:806-808
24. Ishihara T, Higuchi M, Zhang B et al (2001) Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments. J Neurosci 21:6026-6035
25. Ishii K, Ii K, Hasegawa T, Shoji S, Doi A, Mori H (1997) Increased Abeta 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene. Neurosci Lett 228:17-20
26. Karlstrom H, Brooks WS, Kwok JBJ et al (2008) Variable phenotype of Alzheimer's disease with spastic paraparesis. J Neurochem 104:573-583
27. Kwok JBJ, Halliday GM, Brooks WS et al (2003) Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy. J Biol Chem 278:6748-6754
28. Lazarov O, Morfini GA, Pigino G et al (2007) Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's Disease-linked mutant presenilin 1. J Neurosci 27:7011-7020
29. Lippa CF, Saunders AM, Smith TW et al (1996) Familial and sporadic Alzheimer's disease: Neuropathology cannot exclude a final common pathway. Neurology 46:406-412
30. Mann DMA, Pickering-Brown SM, Takeuchi A, Iwatsubo T, Familial Alzheimer's disease pathology study group (2001) Amyloid angiopathy and variability in amyloid-β deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. Am J Pathol 158:2165-2175
31. Mann DMA, Takeuchi A, Sato S et al (2001) Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic β-amyloid pathology known as 'cotton wool' plaques. Neuropathol Appl Neurobiol 27:189-196
32. Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R (1993) An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am J Pathol 142:871-881
33. Masliah E, Sisk A, Mallory M, Games D (2001) Neurofibrillary pathology in transgenic mice overexpressing V717F β-Amyloid precursor protein. J Neuropathol Exp Neurol 60:357-368
34. Meyer-Luehmann M, Spires-Jones TL, Prada C et al (2008) Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease. Nature 451:720-724
35. Mirra SS, Heyman A, McKeel D et al (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 41:479-486
36. Pérez M, Asunción Morán M, Ferrer I et al (2008) Phosphorylated tau in neuritic plaques of APP sw/Tau vlw transgenic mice and Alzheimer disease. Acta Neuropathol 116:409-418
37. Pigino G, Pelsman A, Mori H, Busciglio J (2001) Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. J Neurosci 21:834-842
38. Porzig R, Singer D, Hoffmann R (2007) Epitope mapping of mABs AT8 and Tau5 directed against hyperphosphoylated regions of the human tau protein. Biochem Biophys Res Commun 358:644-649
39. Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45:358-368
40. Savage MJ, Iqbal M, Loh T et al (1994) Cathespin G: Localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein. Neuroscience 60:607-619
41. Scheuner D, Eckman C, Jensen M et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2:850-852
42. Schmidt M, Lee VM, Trojanowski JQ (1989) Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus. Lab Invest 60:513-522
43. Selkoe DJ (1996) (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271:18295-18298
44. Shepherd CE, Gregory GC, Vickers JC et al (2004) Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques. Neurobiol Dis 15:115-119
45. Stanford PM, Shepherd CE, Halliday GM et al (2003) Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 126:814-826
46. Steiner H, Revesz T, Neumann M et al (2001) A pathogenic presenilin-1 deletion causes aberrant Aβ42 production in the absence of congophilic amyloid plaques. J Biol Chem 276:7233-7239
47. Su JH, Cummings BJ, Cotman CW (1996) Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res 739:79-87
48. Su JH, Cummings BJ, Cotman CW (1998) Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites. Acta Neuropathol 96:463-471
49. Takao M, Ghetti B, Hayakawa I et al (2002) A novel mutation (G217D) in the presenilin 1 gene (PSEN1) in a Japanese family: Presenile dementia and Parkinsonism are associated with cotton wool plaques in the cortex and striatum. Acta Neuropathol 104:155-170
50. Takashima A, Murayama M, Murayama O et al (1998) Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau. Proc Natl Acad Sci USA 95:9637-9641
51. Vickers JC, Dickson TC, Adlard PA, Saunders HL, King CE, McCormack G (2000) The cause of neuronal degeneration in Alzheimer's disease. Prog Neurobiol 60:139-165
52. Vickers JC, Riederer BM, Marugg R, Buée-Scherrer V, Buée L, Delacourtes A (1994) Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience 62:1-13
53. Woodhouse A, West AK, Chuckowree JA, Vickers JC, Dickson TC (2005) Does β-amyloid plaque formation cause structural injury to neuronal processes? Neurotox Res 7:5-15
54. Woodhouse A, Vickers JC, Adlard PA, Dickson TC (2007) Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging. Neurobiol Aging (in press). 18 October 2007 [Epub ahead of print]